Bank of America’s Entera Bio ENTX Stock Holding History

Bank of America’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.3K	Sell	12,000 -3,000	-20%	-$4.21K	﹤0.01%	5668
2025 Q4	$29.1K	Sell	15,000 -6,000	-29%	-$14.1K	﹤0.01%	5970
2025 Q3	$40.3K	Sell	21,000 -2,430	-10%	-$4.65K	﹤0.01%	6901
2025 Q2	$44.5K	Sell	23,430 -7,557	-24%	-$14.9K	﹤0.01%	6851
2025 Q1	$52.7K	Buy	30,987 +22,557	+268%	+$49.1K	﹤0.01%	6729
2024 Q4	$17.9K	Hold	8,430	–	–	﹤0.01%	6870
2024 Q3	$16K	Buy	8,430 +5,430	+181%	+$9.64K	﹤0.01%	6791
2024 Q2	$5.52K	Buy	+3,000	New	+$6.57K	﹤0.01%	6990
2022 Q1	–	Sell	-13,866	Closed	-$39K	–	8385
2021 Q4	$39K	Sell	13,866 -2,307	-14%	-$8.64K	﹤0.01%	7311
2021 Q3	$76K	Buy	+16,173	New	+$82.9K	﹤0.01%	6858

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFCM

Seven Fleet Capital Management Mountain View, California $318M AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Bank of America's ENTX Position: Q1 2026 in Review

Bank of America reduced its Entera Bio (ENTX) stake by 20% in Q1 2026, selling an estimated $4.21K and leaving 12,000 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5668.

Bank of America first reported a position in ENTX in Q3 2021 and has held it in 10 quarters since. The position peaked at $76K in Q3 2021. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

Bank of America held 12,000 shares of Entera Bio worth $13.3K as of Q1 2026.
Bank of America sold 3,000 Entera Bio shares in Q1 2026, an estimated $4.21K.
Entera Bio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5668 holding.
Bank of America first reported a position in Entera Bio in Q3 2021 and has held it in 10 quarters since.
Bank of America's Entera Bio position peaked at $76K in Q3 2021.
26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.